Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Beximco Pharmaceuticals Limited Sponsored GDR RegS (GB:BXP)
LSE:BXP
Beximco Pharmaceuticals Limited Sponsored GDR RegS (BXP) Financial Statements
2 Followers
Beximco Pharmaceuticals Limited Sponsored GDR RegS Financial Overview
| Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 9.89B | $ 9.79B | $ 8.74B | $ 8.96B | $ 8.50B |
| Gross Profit | $ 4.44B | $ 4.42B | $ 3.60B | $ 4.05B | $ 4.09B |
| EBIT | $ 1.99B | $ 2.19B | $ 1.22B | $ 1.87B | $ 2.45B |
| EBITDA | $ 1.99B | $ 2.19B | $ 1.35B | $ 1.87B | $ 2.45B |
| Net Income Common Stockholders | $ 1.24B | $ 1.45B | $ 842.68M | $ 1.10B | $ 1.71B |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 1.25B | $ 872.65M | $ 1.17B | $ 589.04M | $ 1.18B |
| Total Assets | $ 69.31B | $ 67.47B | $ 66.15B | $ 65.15B | $ 65.08B |
| Total Debt | $ 11.50B | $ 12.01B | $ 12.37B | $ 11.83B | $ 11.04B |
| Net Debt | $ 10.26B | $ 11.14B | $ 11.20B | $ 11.24B | $ 9.86B |
| Total Liabilities | $ 23.59B | $ 21.43B | $ 21.51B | $ 21.31B | $ 22.28B |
| Stockholders Equity | $ 41.72B | $ 42.04B | $ 40.60B | $ 39.76B | $ 38.66B |
| Cash Flow | - | ||||
| Free Cash Flow | $ 997.78M | $ 2.06M | $ 148.92M | $ 122.04M | $ 836.17M |
| Operating Cash Flow | - | - | - | - | - |
| Investing Cash Flow | $ -680.85M | $ -630.27M | $ -1.10B | $ -165.83M | $ -843.66M |
| Financing Cash Flow | $ -641.49M | $ -363.37M | $ 384.60M | $ -723.07M | $ -501.02M |